Effects of insulin on calcium metabolism and platelet aggregation

Hypertension

Volumn 28, Issue 2, 1996, Pages 209-212

  Ishida, Mari ^a   Ishida, Takafumi ^a   Ono, Norihisa ^a   Matsuura, Hideo ^a   Watanabe, Mitsuaki ^a   Kajiyama, Goro ^a   Kambe, Masayuki ^a   Oshima, Tetsuya ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

calcium; insulin; platelet aggregation; prostaglandins

Indexed keywords

CALCIUM; INSULIN; PROSTAGLANDIN E1;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM METABOLISM; HYPERTENSION; INSULIN METABOLISM; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION;

EID: 0029743495     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.2.209     Document Type: Article

References (33)

1. Mustard JF, Packhan MA, Kinlough-Rathbone RI. Platelets and thrombosis in the development of atherosclerosis and its complications. Adv Exp Med Biol. 1978;102:7-30.
2. Oshima T, Young EW, Bukoski RD, McCarron DA. Abnormal calcium handling by platelets of spontaneously hypertensive rats. Hypertension. 1990;15:606-611.
3. 2+ in hypertensive rats. Hypertension. 1991;18:758-762.
4. Ishida-Kainouchi M, Matsuura H, Ishida T, Kajiyama G, Oshima T. Platelet calcium handling in spontaneously hypertensive rats and in three strains of normotensive rats. J Hypertens. 1993;11:509-514.
5. Koutouzov S, Remmal A, Marche P, Meyer P. Hypersensitivity of phospholipase C in platelets of spontaneously hypertensive rats. Hypertension 1987;10:497-504.
6. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990;39:167-174.
7. Kahn NN, Sinha AK. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase. J Biol Chem. 1990;265:4976-4981.
8. Trovati M, Anfossi G, Cavalot F, Vitali S, Massucco P, Mularoni E, Schinco P, Tamponi G, Emanuelli G. Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes. 1986; 35:818-825.
9. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Emanuelli G. Insulin directly reduces platelet sensitivity to aggregating agents. Diabetes 1998;37:780-786.
10. Standley PR, Ali S, Bapna C, Sowers JR. Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension. Am J Hypertens. 1993;6:938-943.
11. 2+-ATPase activity in kidney basolateral membrane in non-insulin-dependent diabetic rats: effect of insulin. Diabetes. 1986;35:899-905.
12. 2+)ATPaSe activity in canine renal basolateral membrane. Endocrinology. 1986;119:2405-2411.
13. 45Ca] calcium from adipocytes and soleus muscle of the rats. Biochem J. 1977;164:251-255.
14. Hope-Gill HF, Nanda V. Stimulation of calcium ATPase by insulin, glucagon, cyclic AMP and cyclic GMP in triton X-100 extracts of purified rat liver plasma membrane. Horm Metab Res. 1979;11. 698-700.
15. Standley PR, Zhang F, Ram JL, Zemel MB, Sowers JR. Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest. 1991;88:1230-1236.
16. Kim Y-C, Zemel MB. Insulin increases vascular smooth muscle recovery from intracellular calcium loads. Hypertension. 1993;22: 74-77.
17. Kahn NN, Mueller HS, Sinha AK. Restoration by insulin of impaired prostaglandin E1/I2 receptor activity of platelets in acute ischemic heart disease. Circ Res. 1991;68:245-254.
18. Oshima T, Ishida T, Matsuura H, Usguda M, Ishibashi K, Ozono R, Watanabe M, Kajiyama G, Kanbe M. Lack of effect of ouabain on calcium homeostasis in rat platelets: comparative study with human platelets. Am J Physiol. 1994;266:R651-F657.
19. Grynkiewicz G, Poenie M, Tsien RY. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem. 1985;2690:3440-3450.
20. Feinstein MB, Egan JJ, Sha'afi RI, White J. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin). Biochem Biophys Res Commun. 1963;13:598-604.
21. Lanza F, Beretz A, Stierlé A, Corre G, Cazenave J-P. Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization. Thromb Res. 1987;45:477-484.
22. Oda A, Druker BJ, Smith M, Salzman EW. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP. Am J Physiol. 1992;262:C701-C707.
23. Wang DL, Chang YN, Hsu HTC, Usami S, Chien S. Prostaglandin E1 and dibutyryl cyclic AMP enhance platelet resistance to deformation. Thromb Res. 1992;65:757-768.
24. Yamanishi J, Kawahara Y, Fukuzaki H. Effect of cyclic AMP on cytoplasmic free calcium in human platelets stimulated by thrombin: direct measurement with quin2. Thromb Res. 1983;32:183-188.
25. Agranoff BW, Murthy P, Seguin EB. Thrombin-induced phosphodiesteratic cleavage of phosphatidylinositol bisphosphate in human platelets. J Biol Chem. 1983;258:2076-2078.
26. Lapetina EG, Chandrabose KA, Cuatrecasas P. Ionophore A 23187-and thrombin-induced platelet aggregation: independence from cyclooxygenase products. Proc Natl Acad Sci U S A. 1978;75:818-822.
27. 2+ release in saponin-permeabilized platelets. Biochim Biophys Acta 1989;1013:190-193.
28. Salzman EW, Levine L. Cyclic 3′,5′-adenosine monophosphate in human blood platelets. J Clin Invest. 1971;50:131-141.
29. 2+ extrusion from human platelets. Biochim Biophys Acta. 1992;1105:19-28.
30. 2+ uptake in human platelets by cAMP. Biochim Biophys Acta. 1992; 1105:29-39.
31. Waldmann R, Walter U. Cyclic nucleotide elevating vasodilators inhibit platelet aggregation at an early step of the activation cascade. Eur J Pharmacol. 1989;159:317-320.
32. + in deoxycorucosterone acetate salt hypertensive rats. Am J Physiol. 1994;267:R1288-R1293.
33. Ishida T, Ishida M, Matsuura H, Ozono R, Kajiyama G, Oshima T. Dietary salt decreases cytosolic calcium in platelets from Dahl salt-sensitive rats. Am J Physiol. 1995;269:R1225-R1229.